MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Medline Inc.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)
Close on Oct 19, 2026
- Market cap
- $30.29B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 27, 2026 | Aug 5, 2026 | Before market open | $7.70B | $0.07 | $0.50 |
| Q1 FY2026 Ended Mar 28, 2026 | May 6, 2026 | Before market open | $7.40B | $0.16 | $0.33 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 25, 2026 | Before market open | $7.80B | $-0.01 | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | full year 2026 | $3.30B to $3.40B | Lowered |
| Organic Salesnon-GAAP | full year 2026 | 9% to 10% growth | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Medline filed with the SEC
Medline Reports Second Quarter and
Results of operations · EX-99.1 to Form 8-K
Medline Reports First Quarter 2026 Results
Results of operations · EX-99.1 to Form 8-K
Medline Reports Fourth Quarter and Full Year 2025 Results
Results of operations · EX-99.1 to Form 8-K